Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First possible biomarker for liver disease in alpha-1 antitypsin deficiency identified

Nov. 19, 2014

Validation of the antifibrogenic activity of a peripherally restricted CB1 antagonist

Nov. 19, 2014

Tumor antigen-targeted IL-15 complex eliminates lymphoma cells

Nov. 18, 2014

Genetic variant linked to intracranial major artery stenosis/occlusion

Nov. 18, 2014

Phase I results of a tetravalent purified inactivated dengue vaccine

Nov. 18, 2014

Antiobesity hydrogel shows promise in proof-of-concept study

Nov. 18, 2014

RGFP-966, an epigenetic HDAC3 inhibitor, tested in a rat cocaine-abuse model

Nov. 17, 2014

Insulin sparing activity of adenoviral protein E4orf1 may be beneficial for insulin resistance

Nov. 17, 2014

Phase II results for the HBV and HDV entry inhibitor Myrcludex B

Nov. 17, 2014

Non-propagating dengue vaccine induces neonatal immunity in mice

Nov. 17, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...